Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (220)
Dyne Therapeutics, Inc. (DYN)
Friedl-Naderer Johanna — Chief Commercial Officer
Shares
900
Price
$24.35
Total Value
$21.91K
Shares Held After
153,082
% of Holdings
0.6%
Dyne Therapeutics, Inc. (DYN)
Kerr Douglas — Chief Medical Officer
Shares
3,745
Price
$24.35
Total Value
$91.19K
Shares Held After
163,854
% of Holdings
2.2%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D&CMO
Shares
9,705
Price
$26.22
Total Value
$254.50K
Shares Held After
0
% of Holdings
100.0%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
31,500
Price
$103.52
Total Value
$3.26M
Shares Held After
781,709
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$491.69
Total Value
$157.34K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,160
Price
$490.94
Total Value
$569.48K
Shares Held After
324,763
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,514
Price
$490.01
Total Value
$741.87K
Shares Held After
325,923
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,425
Price
$489.12
Total Value
$1.68M
Shares Held After
327,437
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,818
Price
$488.08
Total Value
$1.38M
Shares Held After
330,862
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
223
Price
$486.88
Total Value
$108.57K
Shares Held After
333,680
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$485.85
Total Value
$19.43K
Shares Held After
333,903
% of Holdings
0.0%
YD Bio Ltd (YDES)
Shen Ethan PhD — Director
Shares
18,378
Price
$3.67
Total Value
$67.45K
Shares Held After
11,242,531
% of Holdings
0.2%
VERACYTE, INC. (VCYT)
Chambers Rebecca — Chief Financial Officer
Shares
1,175
Price
$43.71
Total Value
$51.36K
Shares Held After
166,025
% of Holdings
0.7%
VERACYTE, INC. (VCYT)
Chambers Rebecca — Chief Financial Officer
Shares
2,477
Price
$42.81
Total Value
$106.03K
Shares Held After
167,200
% of Holdings
1.5%
VERACYTE, INC. (VCYT)
McGuire Annie — EVP, General Counsel
Shares
1,100
Price
$43.67
Total Value
$48.04K
Shares Held After
131,160
% of Holdings
0.8%
VERACYTE, INC. (VCYT)
McGuire Annie — EVP, General Counsel
Shares
2,154
Price
$42.79
Total Value
$92.17K
Shares Held After
132,260
% of Holdings
1.6%
VERACYTE, INC. (VCYT)
Febbo Phillip G. — Chief Scientific&Med Officer
Shares
2,705
Price
$43.66
Total Value
$118.11K
Shares Held After
133,048
% of Holdings
2.0%
VERACYTE, INC. (VCYT)
Febbo Phillip G. — Chief Scientific&Med Officer
Shares
10,405
Price
$42.89
Total Value
$446.30K
Shares Held After
135,753
% of Holdings
7.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
399
Price
$366.56
Total Value
$146.26K
Shares Held After
1,302,145
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
826
Price
$365.41
Total Value
$301.83K
Shares Held After
1,302,544
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
1,329
Price
$364.48
Total Value
$484.39K
Shares Held After
1,303,370
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
565
Price
$363.34
Total Value
$205.29K
Shares Held After
1,304,699
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
1,992
Price
$362.65
Total Value
$722.40K
Shares Held After
1,305,264
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
1,242
Price
$361.61
Total Value
$449.12K
Shares Held After
1,307,256
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
2,320
Price
$360.47
Total Value
$836.28K
Shares Held After
1,308,498
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
3,392
Price
$359.39
Total Value
$1.22M
Shares Held After
1,310,818
% of Holdings
0.3%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
3,180
Price
$358.42
Total Value
$1.14M
Shares Held After
1,314,210
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
3,962
Price
$357.57
Total Value
$1.42M
Shares Held After
1,317,390
% of Holdings
0.3%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
3,267
Price
$356.37
Total Value
$1.16M
Shares Held After
1,321,352
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
2,006
Price
$355.57
Total Value
$713.28K
Shares Held After
1,324,619
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
520
Price
$354.54
Total Value
$184.36K
Shares Held After
1,326,625
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
405
Price
$366.56
Total Value
$148.46K
Shares Held After
1,347,543
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
847
Price
$365.42
Total Value
$309.51K
Shares Held After
1,347,948
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
1,358
Price
$364.48
Total Value
$494.96K
Shares Held After
1,348,795
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
573
Price
$363.34
Total Value
$208.20K
Shares Held After
1,350,153
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
2,010
Price
$362.65
Total Value
$728.93K
Shares Held After
1,350,726
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
1,214
Price
$361.61
Total Value
$438.99K
Shares Held After
1,352,736
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
2,266
Price
$360.46
Total Value
$816.81K
Shares Held After
1,353,950
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
3,357
Price
$359.39
Total Value
$1.21M
Shares Held After
1,356,216
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
3,143
Price
$358.42
Total Value
$1.13M
Shares Held After
1,359,573
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
3,981
Price
$357.57
Total Value
$1.42M
Shares Held After
1,362,716
% of Holdings
0.3%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
3,297
Price
$356.37
Total Value
$1.17M
Shares Held After
1,366,697
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
2,029
Price
$355.57
Total Value
$721.46K
Shares Held After
1,369,994
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
520
Price
$354.54
Total Value
$184.36K
Shares Held After
1,372,023
% of Holdings
0.0%
Atara Biotherapeutics, Inc. (ATRA)
Cherry Brian N — Director
Shares
104,166
Price
$9.60
Total Value
$999.99K
Shares Held After
166,486
% of Holdings
62.6%
Kymera Therapeutics, Inc. (KYMR)
Adams Brian — Chief Legal Officer
Shares
2,137
Price
$117.57
Total Value
$251.25K
Shares Held After
50,254
% of Holdings
4.1%
Kymera Therapeutics, Inc. (KYMR)
Adams Brian — Chief Legal Officer
Shares
3,025
Price
$116.81
Total Value
$353.35K
Shares Held After
52,391
% of Holdings
5.5%
Kymera Therapeutics, Inc. (KYMR)
Adams Brian — Chief Legal Officer
Shares
1,209
Price
$115.55
Total Value
$139.70K
Shares Held After
55,416
% of Holdings
2.1%
Alector, Inc. (ALEC)
Wong-Sarad Grace — Principal Accounting Officer
Shares
3,625
Price
$2.51
Total Value
$9.09K
Shares Held After
106,015
% of Holdings
3.3%
Caris Life Sciences, Inc. (CAI)
Spetzler David Baxley — President
Shares
119,212
Price
$24.76
Total Value
$2.95M
Shares Held After
1,182,871
% of Holdings
9.2%
Showing 1–50 of 220 transactions (page 1 of 5)